Abstract:Cancer continues to be a global health challenge, with millions suffering from its various forms. Prostate cancer, in particular, emerges as a significant health risk for men. Originating in the prostate gland—a small organ nestled in the male pelvis—this type of cancer the second most common cause of cancer-related deaths among men in the U.S. Despite numerous medical breakthroughs over the years, finding an effective treatment for prostate cancer remains a challenge. Our research is venturing into a new frontier in the fight against prostate cancer, focusing on an innovative method, it explores the potential of nanoparticles for targeted drug delivery. This targeted approach promises to not only intensify the therapeutic effect, but also minimize adverse side effects on healthy cells, ensuring a more balanced and effective treatment regimen. A key in this study is the drug Andrographolide (ADG), which has been previously recognized for its robust anti-cancer properties. However, one of its limitations is its hydrophobicity, which makes it challenging to administer due to solubility concerns. To navigate this challenge, we are pioneering the synthesis of AuAg (gold and silver) graphene quantum dots (GQDs) alloy nanoparticles. AuAg particles, in have been the subject of numerous studies due to their profound impact on cellular processes. By integrating a protective layer of GQDs, we aim to boost the nanoparticles' stability, all while preventing any potential release of harmful metallic ions. The primary objective of this advanced approach is to augment the solubility of andrographolide, paving the way for its targeted and efficient delivery to PC-3 cells. An integral part of our research involves determining the IC50 value, which is pivotal in indicating the concentration at which the drug can inhibit the growth of 50% of prostate cancer cells. Once the IC50 value for the AuAgGQDs is firmly established, our focus will shift to evaluating its effects on the morphology of Red Blood Cells (RBCs). By encapsulating andrographolide within the designed nanoparticles, such as AuAgGQDs and their derivatives, we aim to observe changes in morphology. If there is a change in morphology, it indicates successful drug encapsulation. Through this research, we are not just seeking a viable treatment method, but also aiming to expand the horizons of drug delivery systems. The insights gained from this study could very well revolutionize our understanding of therapeutic potential and underscore the importance of nanoparticles in the realm of biomedical applications. Citation Format: Alondra Del Mar Veloz Bonilla, Brad Weiner, Gerardo Morell, Nataniel Medina-Berríos. Graphene quantum dots-covered AuAg alloy nanoparticles as drug delivery platforms for anticancer applications [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 5757.

Anticancer drugs delivery and adsorption computations in pure and Stone–Wales defect armchair graphene nanoribbons

Adsorption Characteristics of the Anticancer Drug Hydroxyurea with Armchair BN Graphene Nanoribbons Containing and Lacking Vacancy Defects: Insight via DFT Calculations

Assessment of the drug delivery potential of graphene, boron nitride and their in-plane doped structures for hydroxyurea anti-cancer drug via DFT study

Hexagonal boron nitride nanosheet as novel drug delivery system for anticancer drugs: Insights from DFT calculations and molecular dynamics simulations

Understanding the adsorption performance of hetero-nanocages (C12-B6N6, C12-Al6N6, and B6N6-Al6N6) towards hydroxyurea anticancer drug: a comprehensive study using DFT

Understanding the adsorption performance of T-G, T-BN, T-AlN, and T-GaN nanosheets toward the thioguanine anticancer drug via DFT calculations

The first principal study of decorated hexagonal boron nitride nanosheets with Ni and Pd atoms as drug carrier

Investigation of the solvent effect, molecular structure, electronic properties and adsorption mechanism of Tegafur anticancer drug on Graphene nanosheet surface as drug delivery system by molecular dynamics simulation and density functional approach

Theoretical Study on the Aggregation and Adsorption Behaviors of Anticancer Drug Molecules on Graphene/Graphene Oxide Surface

Fluorinated graphene as an anticancer nanocarrier: an experimental and DFT study

Revealing the role of different nitrogen functionalities in the drug delivery performance of graphene quantum dots: a combined density functional theory and molecular dynamics approach

Doxorubicin Encapsulation in Carbon Nanotubes Having Haeckelite or Stone–Wales Defects as Drug Carriers: A Molecular Dynamics Approach

Computational assessment of the use of graphene‐based nanosheets as PtII chemotherapeutics delivery systems

Comparative prediction of binding affinity of Hydroxyurea anti-cancer to boron nitride and carbon nanotubes as smart targeted drug delivery vehicles

Abstract 5756: Silver graphene quantum dots as drug delivery platforms for anti-cancer application

Molecular Dynamics Simulations of Docetaxel Adsorption on Graphene Quantum Dots Surface Modified by PEG-b-PLA Copolymers

GeSe nanoclusters as potential drug delivery agent for anti-cancer drugs: First-principles study

Surface adsorption of nitrosourea on pristine and doped (Al, Ga and In) boron nitride nanosheets as anticancer drug carriers: the DFT and COSMO insights

Physicochemical and in vitro characterization of Agarose based nanocarriers incorporated with Graphene Quantum Dots/ α-Fe2O3 for targeted drug delivery of Quercetin to liver cancer treatment

Physico-chemical properties and biological evaluation of graphene quantum dots for anticancer drug susceptibility

Abstract 5757: Graphene quantum dots-covered AuAg alloy nanoparticles as drug delivery platforms for anticancer applications